New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
April 21, 2015
09:02 EDTHUMHumana at Home acquires Your Home Advantage, terms not disclosed
Subscribe for More Information
April 20, 2015
16:09 EDTBSXBoston Scientific announces long-term data underscore safety, efficacy of S-ICD
The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific S-ICD System for patients at risk of sudden cardiac arrest. The study, "Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry" was led by Dr. Martin Burke, professor of medicine at the University of Chicago. The analysis combined data from two large S-ICD studies to provide the most comprehensive look at S-ICD System patient outcomes to date. The all-cause mortality rate for the S-ICD patients was 1.6% per year, comparing favorably to observed mortality rates in similar TV-ICD studies. Currently, the S-ICD System is covered nationally by Medicare, Aetna, Cigna and others, and regionally by numerous private and Medicaid plans, providing coverage for approximately 170M individuals in the U.S. The S-ICD System has been commercially available in Europe since 2009.
09:03 EDTSTJSt. Jude Medical announces intent to acquire Spinal Modulation
Subscribe for More Information
07:44 EDTBSXSurvey shows strong momentum for Boston Scientific devices, says RBC Capital
RBC Capital says that its survey supports strong momentum for Boston Scientific's S-ICD and Watchman, and the firm thinks the company is probably gaining share in single-chamber ICDs. The firm raised its price target on the shares to $20 from $17 and recommends buying the shares at current levels or on pullbacks.
April 17, 2015
08:04 EDTCNCCentene's Nurtur receives full URAC accreditation
Centene announced that Nurtur, its health and wellness subsidiary, received full Disease Management Accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
07:10 EDTMDTMedtronic's Solitaire improved neurological outcomes in stroke patients in trial
Subscribe for More Information
April 16, 2015
16:11 EDTBSXBoston Scientific enrolls first patient REDUCE-HTN: REINFORCE study
Boston Scientific announced the first patient in the REDUCE-HTN: REINFORCE study was enrolled this week at Cardiology P.C. at Princeton Baptist Medical Center in Birmingham, AL by Farrell Mendelsohn, M.D., site principal investigator, and referred by Michael Wilensky, M.D. Boston Scientific received an investigational device exemption, or IDE, for the study from the FDA in December.
12:37 EDTUNHOn The Fly: Top stock stories at midday
Subscribe for More Information
07:19 EDTUNHOptions expected to be active: NFLX SNDK UNH PNRA C GS SLB
06:08 EDTUNHUnitedHealth added 1.6M more people domestically in the past year
Subscribe for More Information
06:08 EDTUNHUnitedHealth reports Optum revenue $12.8B
Subscribe for More Information
06:06 EDTUNHUnitedHealth reports Q1 medical care ratio down 140 basis points to 81.1%
The first quarter operating cost ratio of 16.6% increased 20 basis points year-over-year due to higher growth in services businesses. The first quarter tax rate of 43.3% increased 130 basis points year-over-year due to higher levels of nondeductible ACA fees. First quarter days sales outstanding of 13 days increased 1 day year-over-year, due to higher growth in government programs. Days claims payable was flat year-over-year at 47 days.
06:05 EDTUNHUnitedHealth says Catamaran combination to contribute 30c to 2016 earnings
06:05 EDTUNHUnitedHealth raises FY15 EPS to $6.15-$6.30 from $6.00-$6.25, consensus $6.21
Subscribe for More Information
06:01 EDTUNHUnitedHealth reports Q1 EPS $1.46, consensus $1.35
Subscribe for More Information
April 15, 2015
14:46 EDTUNHUnitedHealth technical notes before earnings
Subscribe for More Information
14:21 EDTUNHUnitedHealth April volatility elevated into Q1 and outlook
UnitedHealth April call option implied volatility is at 58, May is at 26, June is at 23; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on April 16.
11:51 EDTUNHExpress Scripts down 2% as Walgreens speaks at analyst day
Subscribe for More Information
April 14, 2015
11:04 EDTMDTMedtronic to develop stent graft system under patent agreement with Sanford
Subscribe for More Information
09:16 EDTMDTMedtronic announces CE Mark for Micra TPS
Subscribe for More Information
09:09 EDTBSXBoston Scientific announces strategic alliance with Frankenman
Boston Scientific announced the signing of a strategic alliance with Frankenman Medical Equipment Company, a recognized leader with deep local market expertise in the China surgical devices market. This alliance is expected to enable Boston Scientific and Frankenman to reach more clinicians and treat more patients by providing access to training on less invasive endoscopic technologies and the clinical and economic benefits these therapies can provide. CPEChina Fund, an entity of CITIC PE, is a current shareholder of Frankenman and will continue to support the company's growth in alignment with this strategic partnership.Under the terms of the agreement, Boston Scientific will become a shareholder of Frankenman, and provide services and expertise to Frankenman to support its continued growth, development pipeline and manufacturing capabilities. The transaction is expected to close in the first half of 2015, subject to customary closing conditions.
April 13, 2015
17:13 EDTMDTIBM Medtronic to partner to improve diabetes care
IBM (IBM) and Medtronic (MDT) announced that they will work together to combine powerful analytics and cognitive computing with diabetes medical devices and health data to develop a new generation of personalized diabetes management solutions. People using Medtronic diabetes solutions could benefit from new solutions developed in collaboration with IBM's newly-formed Watson Health unit.
17:10 EDTMDTIBM establishes a Watson Health Cloud
Subscribe for More Information
10:58 EDTCI, HNT, AET, MOH, WCG, CNC, UNH, HUMCigna, Humana seen as potential takeover targets in Managed Care space
Subscribe for More Information
10:00 EDTSTJ, UNHOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:33 EDTHUM, CI, UNH, MOH, AET, HNT, CNC, WCGJefferies sees low probability of WellCare, Centene buyouts
After running several acquisition scenarios for the Managed Care space, Jefferies says potential takeovers of WellCare (WCG) and Centene (CNC) are "hard to justify." The firm estimates acquirers will only be able to generate 1%-3% accretion from buying either company at a 20% premium to current share prices. The deal that makes the most financial sense is Aetna (AET) buying Cigna (CI), Jefferies says today in a note to investors. Also financially attractive would be a buyout of Humana (HUM) by either Anthem (ANTM) or Aetna, the firm adds. After analyzing the Managed Care space, it upgraded this morning shares of UnitedHealth (UNH) to Buy from Hold with a $141 price target. Jefferies also has Buy ratings on Aetna, Anthem, Health Net (HNT) and Molina Healthcare (MOH).
07:03 EDTUNHUnitedHealth upgraded to Buy from Hold at Jefferies
Jefferies upgraded UnitedHealth to Buy saying the company's outlook continues to improve. It believes headwinds are turning to tailwinds in UNH's Medicare Advantage business and raised its price target for shares to $141 from $106.
06:33 EDTSTJSt. Jude Medical upgraded to Neutral from Underperform at Credit Suisse
Subscribe for More Information
April 10, 2015
15:37 EDTMDTMedtronic looking to sell medical supplies business, dealReporter says
Subscribe for More Information
07:35 EDTMDTExpert comments bullish for Edwards, Medtronic, says RBC Capital
Subscribe for More Information
April 9, 2015
09:21 EDTCI, UNHCatamaran said to be likley to keep Cigna contract, CT Financial News reports
Brain Tanquilut, senior VP, Healthcare Services Equity Research at Jefferies, believes there is "precedent out there that suggests Catamaran’s (CTRX) contract with Cigna (CI) "is safe” despite UnitedHealth's (UNH) recent deal to buy the pharmacy benefits manager, according to CT Financial News. Reference Link
07:29 EDTUNHUnitedHealth April volatility elevated into Q1 and outlook
UnitedHealth April call option implied volatility is at 34, May is at 25, June is at 21; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on April 16.
April 8, 2015
07:24 EDTMDTNeurotechnology Industry Organization to hold a conference
Subscribe for More Information
April 7, 2015
10:23 EDTHUM, AET, CI, UNHMedicare Advantage 2016 rates set above expectations
The U.S. yesterday announced higher than expected 2016 Medicare Advantage reimbursement rates. The news is seen as benefiting managed care companies with large exposure to the Medicare Advantage program. WHAT'S NEW: The Centers for Medicare and Medicaid Services, or CMS, yesterday afternoon announced that Medicare Advantage reimbursement rates would rise 1.25% in 2016 from 2015 levels. In February, CMS proposed a 0.95% reduction in Medicare Advantage reimbursement rates for 2016. This year, reimbursement rates have fallen 4%. WHAT'S NOTABLE: Humana (HUM) said this morning in a regulatory filing that based on its review of the Final Rate Notice, the company expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation, the company explained. ANALYST REACTION: In a note to investors earlier today, Deutsche Bank analyst Scott Fidel wrote that this is the first time in seven years that CMS has implemented an increase in Medicare Advantage rates. However, noting that CMS said it had raised its estimates for Medicare costs, Fidel added that this forecast tempered the positive outlook created by the reimbursement increase. The analyst kept Buy ratings on the following stocks in the sector: Aetna (AET), Anthem (ANTM), Cigna (CI), Magellan Health (MGLN), and UnitedHealth (UNH). Stifel analysts said that the results were modestly better than expected, except for the agency's decision not to make a Star rating adjustment for plans with certain higher acuity populations. The firm thinks that more diversified managed care companies with Medicare Advantage products could be boosted by CMS' decision, identifying Aetna, Humana, and UnitedHealth as being among the companies in that category. PRICE ACTION: In early trading, Aetna was little changed at $107.40, Anthem was flat near $155 per share, Cigna slipped 0.4% to $131.34, Magellan was flat at $71, UnitedHealth added 0.5% to $118.31 and Humana gained fractionally to $178.54.
08:57 EDTHUMHumana sees average Medicare Advantage funding from CMS up 0.8% for 2016
Humana noted that on Monday, April 6, after the market close, the Centers for Medicare and Medicaid Services, or CMS, announced final 2016 Medicare benchmark payment rates and related technical factors impacting the bid benchmark premiums, as expected, following the February 20 release of the preliminary 2016 Medicare Advantage benchmark payment rates. Humana said in its regulatory filing that based on its review of the Final Rate Notice, Humana expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. The Final Rate Notice from CMS estimates an average funding increase of 1.25% for the MA program, versus its estimate of a funding decline of 0.95% per the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation. The company is completing more detailed analyses of the Final Rate Notice and the commensurate impacts on its 2016 Medicare benefit offerings, including geographic-specific impacts, and anticipates further discussion in its Q1 earnings call on April 29. Bid designs for the company’s 2016 Medicare Advantage offerings are due to CMS on June 1, the company noted.
08:20 EDTHUM, AET, WCG, CI, HNTCowen expects managed care stocks to outperform following CMS release
Cowen expects managed care stocks to outperform today following the CMS release outlining better than expected Medicare Advantage rates for 2016. The firm also sees improved FFS growth rates, maintained coding intensity adjustment, and continued HRA payments. Publicly traded companies in the space include Aetna (AET), Cigna (CI), Health Net (HNT), Humana (HUM), and WellCare (WCG).
07:57 EDTCI, UNH, WCG, HUMManaged care companies likely to rise on CMS news, says Oppenheimer
Subscribe for More Information
07:44 EDTAET, UNH, HUMSome managed care stocks could be boosted by CMS decision, says Stifel
Subscribe for More Information
07:41 EDTAET, WCG, HUM, CI, UNH, HNT2016 MA rates positive for first time in seven years, says Deutsche Bank
Deutsche Bank notes that for the first time since 2009, Medicare Advantage rates will be positive after the Centers for Medicare and Medicaid Services announced yesterday that final 2016 rates will rise by 1.25%, representing a 220 basis points favorable swing from the preliminary proposed cut of 0.95%. Deutsche says the positive surprise is "somewhat tempered" by the more cautious view on Medicare cost trends provided by the CMS actuaries in the final 2016 rate announcement. The firm expects Humana (HUM), Health Net (HNT) and UnitedHealth (UNH), Aetna (AET) and Anthem (ANTM) to experience Medicare Advantage rate increases.
07:39 EDTMOH, HNT, WCGSome managed care stocks could be pressured by CMS decision, says Stifel
Subscribe for More Information
06:56 EDTAETAetna CEO sees 'groundswell' of wage increases in coming months, WSJ reports
Mark Bertolini, the CEO of Aetna, says he believes there will be a "groundswell" of pay increases for the lowest-paid employees at big companies in the next few months, The Wall Street Journal reports. Bertolini commented at a Peterson Institute for International Economics event that he believes "there are a number of CEOs that will come out in the next six months with wage increases that will matter." Reference Link
05:48 EDTUNHCatamaran downgraded to Hold from Buy at Jefferies
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use